KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Reports Fiscal Third Quarter Results Mar 14, 2019 KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2019 Feb 25, 2019 KalVista Pharmaceuticals Appoints Brian J. G. Pereira, MD to Board of Directors Feb 1, 2019 All News
KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2019 Feb 25, 2019
